| Familial gastric cancer: overview and guidelines for management C Caldas, F Carneiro, HT Lynch, J Yokota, GL Wiesner, SM Powell, ... Journal of medical genetics 36 (12), 873-880, 1999 | 813 | 1999 |
| Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation G Keller, H Vogelsang, I Becker, J Hutter, K Ott, S Candidus, T Grundei, ... The American journal of pathology 155 (2), 337-342, 1999 | 363 | 1999 |
| Germline CDH1 deletions in hereditary diffuse gastric cancer families C Oliveira, J Senz, P Kaurah, H Pinheiro, R Sanges, A Haegert, G Corso, ... Human molecular genetics 18 (9), 1545-1555, 2009 | 268 | 2009 |
| Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) F Lordick, B Luber, S Lorenzen, S Hegewisch-Becker, G Folprecht, E Wöll, ... British journal of cancer 102 (3), 500-505, 2010 | 246 | 2010 |
| Gastric adenocarcinoma: pathomorphology and molecular pathology M Werner, KF Becker, G Keller, H Höfler Journal of cancer research and clinical oncology 127, 207-216, 2001 | 222 | 2001 |
| TFAP2E–DKK4 and Chemoresistance in Colorectal Cancer MPA Ebert, M Tänzer, B Balluff, E Burgermeister, AK Kretzschmar, ... New England Journal of Medicine 366 (1), 44-53, 2012 | 211 | 2012 |
| Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes SM Woerner, A Benner, C Sutter, M Schiller, YP Yuan, G Keller, P Bork, ... Oncogene 22 (15), 2226-2235, 2003 | 196 | 2003 |
| Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence AK Walch, HF Zitzelsberger, J Bruch, G Keller, D Angermeier, MM Aubele, ... The American journal of pathology 156 (2), 555-566, 2000 | 190 | 2000 |
| Genotype-Phenotype Comparison of German MLH1 and MSH2 Mutation Carriers Clinically Affected With Lynch Syndrome: A Report by the German HNPCC … T Goecke, K Schulmann, C Engel, E Holinski-Feder, C Pagenstecher, ... Journal of clinical oncology 24 (26), 4285-4292, 2006 | 188 | 2006 |
| p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease L Quintanilla-Martinez, M Kremer, G Keller, M Nathrath, ... The American journal of pathology 159 (6), 2095-2105, 2001 | 174 | 2001 |
| Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas M Jesinghaus, B Konukiewitz, G Keller, M Kloor, K Steiger, M Reiche, ... Modern Pathology 30 (4), 610-619, 2017 | 167 | 2017 |
| Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer M Maak, I Simon, U Nitsche, P Roepman, M Snel, AM Glas, T Schuster, ... Annals of surgery 257 (6), 1053-1058, 2013 | 163 | 2013 |
| The use of molecular biology in diagnosis and prognosis of gastric cancer KF Becker, G Keller, H Hoefler Surgical oncology 9 (1), 5-11, 2000 | 161 | 2000 |
| Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer E Mangold, C Pagenstecher, W Friedl, M Mathiak, R Buettner, C Engel, ... International journal of cancer 116 (5), 692-702, 2005 | 152 | 2005 |
| DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer K Mutze, R Langer, F Schumacher, K Becker, K Ott, A Novotny, ... European journal of cancer 47 (12), 1817-1825, 2011 | 138 | 2011 |
| Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC M Morak, HK Schackert, N Rahner, B Betz, M Ebert, C Walldorf, ... European journal of human genetics 16 (7), 804-811, 2008 | 135 | 2008 |
| Germline mutations of the E-cadherin (CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients G Keller, H Vogelsang, I Becker, S Plaschke, K Ott, G Suriano, AR Mateus, ... Journal of medical genetics 41 (6), e89-e89, 2004 | 132 | 2004 |
| Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer Y Mueller-Koch, H Vogelsang, R Kopp, P Lohse, G Keller, D Aust, ... Gut 54 (12), 1733-1740, 2005 | 131 | 2005 |
| Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR M Bettstetter, S Dechant, P Ruemmele, M Grabowski, G Keller, ... Clinical cancer research 13 (11), 3221-3228, 2007 | 125 | 2007 |
| Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal … C Engel, J Forberg, E Holinski‐Feder, C Pagenstecher, J Plaschke, ... International journal of cancer 118 (1), 115-122, 2006 | 122 | 2006 |
